ref_name,rx_name,iso_name,section,assay_name,potency_type,potency,cumulative_count,potency_upper_limit,potency_lower_limit,potency_unit,date_added
Noske22,Nirmatrelvir,3CLpro:M49I,Table 2,FRET,IC50,17.1,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:M49T,Table 2,FRET,IC50,16.9,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:N142S,Table 2,FRET,IC50,29,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:N142D,Table 2,FRET,IC50,32,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:G143S,Table 2,FRET,IC50,3380,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:M165I,Table 2,FRET,IC50,19,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:R188K,Table 2,FRET,IC50,17,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:R188S,Table 2,FRET,IC50,61,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:Q189K,Table 2,FRET,IC50,203,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:T190I,Table 2,FRET,IC50,25,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:A191T,Table 2,FRET,IC50,27,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:A191V,Table 2,FRET,IC50,46,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:A193S,Table 2,FRET,IC50,27,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:A193T,Table 2,FRET,IC50,32,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:A193V,Table 2,FRET,IC50,11,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,Wuhan-Hu-1,Table 2,FRET,IC50,21.9,1,9830.4,0.6,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:M49I,Table 2,FRET,Ki,10.4,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:M49T,Table 2,FRET,Ki,9.6,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:N142S,Table 2,FRET,Ki,11.5,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:N142D,Table 2,FRET,Ki,16.45,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:G143S,Table 2,FRET,Ki,960.2,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:M165I,Table 2,FRET,Ki,11.1,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:R188K,Table 2,FRET,Ki,9,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:R188S,Table 2,FRET,Ki,18.95,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:Q189K,Table 2,FRET,Ki,106.7,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:T190I,Table 2,FRET,Ki,13.2,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:A191T,Table 2,FRET,Ki,13.2,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:A191V,Table 2,FRET,Ki,16.9,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:A193S,Table 2,FRET,Ki,15.8,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:A193T,Table 2,FRET,Ki,18.2,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,3CLpro:A193V,Table 2,FRET,Ki,4.8,1,NULL,NULL,nM,2022-11-08
Noske22,Nirmatrelvir,Wuhan-Hu-1,Table 2,FRET,Ki,6.5,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:M49I,Table 2,FRET,IC50,139,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:M49T,Table 2,FRET,IC50,73,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:N142S,Table 2,FRET,IC50,67,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:N142D,Table 2,FRET,IC50,48,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:G143S,Table 2,FRET,IC50,197,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:M165I,Table 2,FRET,IC50,32,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:R188K,Table 2,FRET,IC50,38,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:R188S,Table 2,FRET,IC50,74,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:Q189K,Table 2,FRET,IC50,38,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:T190I,Table 2,FRET,IC50,44,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:A191T,Table 2,FRET,IC50,67,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:A191V,Table 2,FRET,IC50,48,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,Wuhan-Hu-1,Table 2,FRET,IC50,13,1,2048,0.25,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:M49I,Table 2,FRET,Ki,54.2,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:M49T,Table 2,FRET,Ki,31.6,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:N142S,Table 2,FRET,Ki,40.4,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:N142D,Table 2,FRET,Ki,23.2,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:G143S,Table 2,FRET,Ki,141.3,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:M165I,Table 2,FRET,Ki,13.9,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:R188K,Table 2,FRET,Ki,17.2,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:R188S,Table 2,FRET,Ki,51.3,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:Q189K,Table 2,FRET,Ki,8.3,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:T190I,Table 2,FRET,Ki,21.6,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:A191T,Table 2,FRET,Ki,34.6,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,3CLpro:A191V,Table 2,FRET,Ki,30.7,1,NULL,NULL,nM,2022-11-08
Noske22,Ensitrelvir,Wuhan-Hu-1,Table 2,FRET,Ki,8.9,1,NULL,NULL,nM,2022-11-08
